Latest Breaking News On - Some vocs - Page 1 : comparemela.com

Published: Apr 07, 2021    - Program Powered by Applied DNA’s Mutation-targeted qPCR Assays and NGS Platform - - Program Data Potentially Relevant to COVID-19 Vaccine and Therapeutics Developers, Precision Medicine -   STONY BROOK & NEW HYDE PARK, N.Y. (BUSINESS WIRE) Applied DNA Sciences, Inc.. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and Northwell Health (Northwell) today announced their entry into a pro bono Material Transfer Agreement (MTA) that establishes a real-time surveillance program for the tracking and identification of SARS-CoV-2 mutations and variants of concern (VoCs) in Northwell’s COVID-positive specimens (the “Program”). Under the Program, de-identified positive COVID-19 specimens supplied by Northwell are being screened for SARS-CoV-2 mutations found in currently known VoCs using Applied DNA’s Linea

New yorkUnited statesStony brookDwayne allen breiningJamesa haywardNorthwell health is new yorkNorthwell health physician partnersCompany assay kitHofstra northwell school of nursingYork state department of healthSciences incMutation panelNorthwell healthResearch use onlyDrug administrationNorthwell health labs